Yuyu Pharma, Inc. (000220) Price & Analysis

― Followers

000220 Stock Chart & Stats

₩3570.00

₩60.00(1.71%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range₩3,320.00 - ₩5,100.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)134.72K

Market Cap

₩51.63B

Enterprise ValueN/A

Total Cash (Recent Filing)₩29.89B

Total Debt (Recent Filing)₩26.21B

Price to Earnings (P/E)6.8

Beta0.19

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)526.87

Shares Outstanding15,747,462

10 Day Avg. Volume77,010

30 Day Avg. Volume134,720

Financial Highlights & Ratios

PEG Ratio1.80

Price to Book (P/B)0.58

Price to Sales (P/S)0.53

P/FCF Ratio9.59

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

000220 FAQ

What was Yuyu Pharma, Inc.’s price range in the past 12 months?

Yuyu Pharma, Inc. lowest stock price was ₩3320.00 and its highest was ₩5100.00 in the past 12 months.

What is Yuyu Pharma, Inc.’s market cap?

Yuyu Pharma, Inc.’s market cap is ₩51.63B.

When is Yuyu Pharma, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Yuyu Pharma, Inc.’s earnings last quarter?

Yuyu Pharma, Inc. released its earnings results on May 15, 2026. The company reported ₩216.566 earnings per share for the quarter, beating the consensus estimate of N/A by ₩216.566.

Is Yuyu Pharma, Inc. overvalued?

According to Wall Street analysts Yuyu Pharma, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Yuyu Pharma, Inc. pay dividends?

Yuyu Pharma, Inc. does not currently pay dividends.

What is Yuyu Pharma, Inc.’s EPS estimate?

Yuyu Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Yuyu Pharma, Inc. have?

Yuyu Pharma, Inc. has 15,747,462 shares outstanding.

What happened to Yuyu Pharma, Inc.’s price movement after its last earnings report?

Yuyu Pharma, Inc. reported an EPS of ₩216.566 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.728%.

Which hedge fund is a major shareholder of Yuyu Pharma, Inc.?

Currently, no hedge funds are holding shares in KR:000220

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Yuyu Pharma, Inc.

Yuyu Pharma, Inc. specializes in the development and commercialization of pharmaceutical products. Its extensive portfolio of prescription medications addresses a wide range of conditions, including osteoporosis, disorders related to brain-bone metabolism and hypocalcemia, cerebral and peripheral circulatory issues, thromboembolic events, respiratory ailments, hypertension, pulmonary tuberculosis, joint inflammation (arthrifuge), diabetic neuropathy, and eczematous dermatitis. The company also offers other treatments for the circulatory system, various antibiotics, and skeletal muscle relaxants. Beyond prescription items, Yuyu Pharma provides over-the-counter (OTC) drugs and nutritional supplements. Established in 1941, the company is headquartered in Seoul, South Korea. It adopted its current name, Yuyu Pharma, Inc., in May 2008, having previously operated as YuYu Inc.